| UniProt ID | GRPE1_HUMAN | |
|---|---|---|
| UniProt AC | Q9HAV7 | |
| Protein Name | GrpE protein homolog 1, mitochondrial | |
| Gene Name | GRPEL1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 217 | |
| Subcellular Localization | Mitochondrion matrix . | |
| Protein Description | Essential component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner (By similarity). Seems to control the nucleotide-dependent binding of mitochondrial HSP70 to substrate proteins. [PubMed: 11311562] | |
| Protein Sequence | MAAQCVRLARRSLPALALSLRPSPRLLCTATKQKNSGQNLEEDMGQSEQKADPPATEKTLLEEKVKLEEQLKETVEKYKRALADTENLRQRSQKLVEEAKLYGIQAFCKDLLEVADVLEKATQCVPKEEIKDDNPHLKNLYEGLVMTEVQIQKVFTKHGLLKLNPVGAKFDPYEHEALFHTPVEGKEPGTVALVSKVGYKLHGRTLRPALVGVVKEA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 19 | Phosphorylation | SLPALALSLRPSPRL HCCHHHHHCCCCCCE | 19.41 | 24719451 | |
| 23 | Phosphorylation | LALSLRPSPRLLCTA HHHHCCCCCCEEEEE | 19.07 | 30301811 | |
| 44 | Sulfoxidation | GQNLEEDMGQSEQKA CCCHHHHHCCCHHHC | 6.27 | 28465586 | |
| 47 | Phosphorylation | LEEDMGQSEQKADPP HHHHHCCCHHHCCCC | 35.94 | 20068231 | |
| 50 | Ubiquitination | DMGQSEQKADPPATE HHCCCHHHCCCCCCH | 51.18 | 23503661 | |
| 50 | Acetylation | DMGQSEQKADPPATE HHCCCHHHCCCCCCH | 51.18 | 26051181 | |
| 64 | Ubiquitination | EKTLLEEKVKLEEQL HHHHHHHHHHHHHHH | 34.98 | 29967540 | |
| 64 | Acetylation | EKTLLEEKVKLEEQL HHHHHHHHHHHHHHH | 34.98 | 25953088 | |
| 64 | Malonylation | EKTLLEEKVKLEEQL HHHHHHHHHHHHHHH | 34.98 | 32601280 | |
| 66 | Acetylation | TLLEEKVKLEEQLKE HHHHHHHHHHHHHHH | 62.34 | 23749302 | |
| 66 | Ubiquitination | TLLEEKVKLEEQLKE HHHHHHHHHHHHHHH | 62.34 | 23503661 | |
| 72 | Ubiquitination | VKLEEQLKETVEKYK HHHHHHHHHHHHHHH | 51.54 | 23503661 | |
| 72 | Acetylation | VKLEEQLKETVEKYK HHHHHHHHHHHHHHH | 51.54 | 25953088 | |
| 72 | Succinylation | VKLEEQLKETVEKYK HHHHHHHHHHHHHHH | 51.54 | 23954790 | |
| 77 | Ubiquitination | QLKETVEKYKRALAD HHHHHHHHHHHHHHC | 52.30 | 23503661 | |
| 77 | Acetylation | QLKETVEKYKRALAD HHHHHHHHHHHHHHC | 52.30 | 25953088 | |
| 94 | Acetylation | NLRQRSQKLVEEAKL HHHHHHHHHHHHHHH | 56.60 | 23749302 | |
| 94 | Malonylation | NLRQRSQKLVEEAKL HHHHHHHHHHHHHHH | 56.60 | 32601280 | |
| 94 | Succinylation | NLRQRSQKLVEEAKL HHHHHHHHHHHHHHH | 56.60 | 27452117 | |
| 94 | Succinylation | NLRQRSQKLVEEAKL HHHHHHHHHHHHHHH | 56.60 | - | |
| 100 | Succinylation | QKLVEEAKLYGIQAF HHHHHHHHHHHHHHH | 45.59 | 23954790 | |
| 100 | Acetylation | QKLVEEAKLYGIQAF HHHHHHHHHHHHHHH | 45.59 | 25953088 | |
| 102 | Phosphorylation | LVEEAKLYGIQAFCK HHHHHHHHHHHHHHH | 16.10 | 28152594 | |
| 120 | Succinylation | EVADVLEKATQCVPK HHHHHHHHHHCCCCH | 53.20 | - | |
| 120 | Acetylation | EVADVLEKATQCVPK HHHHHHHHHHCCCCH | 53.20 | 26051181 | |
| 120 | Succinylation | EVADVLEKATQCVPK HHHHHHHHHHCCCCH | 53.20 | - | |
| 124 | Glutathionylation | VLEKATQCVPKEEIK HHHHHHCCCCHHHHC | 5.00 | 22555962 | |
| 127 | Acetylation | KATQCVPKEEIKDDN HHHCCCCHHHHCCCC | 47.81 | 26822725 | |
| 157 | Acetylation | QIQKVFTKHGLLKLN HHHHHHHHCCCEEEC | 24.98 | 23749302 | |
| 157 | Succinylation | QIQKVFTKHGLLKLN HHHHHHHHCCCEEEC | 24.98 | 27452117 | |
| 162 | Acetylation | FTKHGLLKLNPVGAK HHHCCCEEECCCCCC | 51.79 | 25825284 | |
| 169 | Ubiquitination | KLNPVGAKFDPYEHE EECCCCCCCCCCCCE | 44.35 | 29967540 | |
| 169 | Acetylation | KLNPVGAKFDPYEHE EECCCCCCCCCCCCE | 44.35 | 25953088 | |
| 173 | Phosphorylation | VGAKFDPYEHEALFH CCCCCCCCCCEECCC | 31.59 | 28152594 | |
| 181 | Phosphorylation | EHEALFHTPVEGKEP CCEECCCCCCCCCCC | 22.99 | 28152594 | |
| 186 | Malonylation | FHTPVEGKEPGTVAL CCCCCCCCCCCCEEE | 47.43 | 32601280 | |
| 186 | Acetylation | FHTPVEGKEPGTVAL CCCCCCCCCCCCEEE | 47.43 | 25953088 | |
| 195 | Phosphorylation | PGTVALVSKVGYKLH CCCEEEEEECCCEEC | 23.60 | 20068231 | |
| 200 | Acetylation | LVSKVGYKLHGRTLR EEEECCCEECCCCCC | 28.25 | 27452117 | |
| 205 | Phosphorylation | GYKLHGRTLRPALVG CCEECCCCCCHHHHH | 31.54 | 20068231 | |
| 215 | Acetylation | PALVGVVKEA----- HHHHHHHCCC----- | 45.58 | 19608861 | |
| 215 | Succinylation | PALVGVVKEA----- HHHHHHHCCC----- | 45.58 | - | |
| 215 | Succinylation | PALVGVVKEA----- HHHHHHHCCC----- | 45.58 | - | |
| 215 | Ubiquitination | PALVGVVKEA----- HHHHHHHCCC----- | 45.58 | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GRPE1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GRPE1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GRPE1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GRPE1_HUMAN | GRPEL1 | physical | 23345595 | |
| CCAR1_HUMAN | CCAR1 | physical | 26186194 | |
| PALLD_HUMAN | PALLD | physical | 26186194 | |
| GRPE2_HUMAN | GRPEL2 | physical | 26186194 | |
| AHNK_HUMAN | AHNAK | physical | 26344197 | |
| DNJA4_HUMAN | DNAJA4 | physical | 26344197 | |
| DNJB1_HUMAN | DNAJB1 | physical | 26344197 | |
| DNJB4_HUMAN | DNAJB4 | physical | 26344197 | |
| DNJC3_HUMAN | DNAJC3 | physical | 26344197 | |
| DUT_HUMAN | DUT | physical | 26344197 | |
| HSP72_HUMAN | HSPA2 | physical | 26344197 | |
| HSP74_HUMAN | HSPA4 | physical | 26344197 | |
| HS74L_HUMAN | HSPA4L | physical | 26344197 | |
| HSP7C_HUMAN | HSPA8 | physical | 26344197 | |
| HS105_HUMAN | HSPH1 | physical | 26344197 | |
| ITPA_HUMAN | ITPA | physical | 26344197 | |
| MDHM_HUMAN | MDH2 | physical | 26344197 | |
| STIP1_HUMAN | STIP1 | physical | 26344197 | |
| STMN1_HUMAN | STMN1 | physical | 26344197 | |
| TIM44_HUMAN | TIMM44 | physical | 26344197 | |
| PALLD_HUMAN | PALLD | physical | 28514442 | |
| GRP75_HUMAN | HSPA9 | physical | 28514442 | |
| GRPE2_HUMAN | GRPEL2 | physical | 28514442 | |
| TPPP_HUMAN | TPPP | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-157 AND LYS-215, AND MASSSPECTROMETRY. | |